TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.21), $0.05 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $21.28 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Myriad Uranium completes acquisition of Rush Rare Metals